未登录

B

Bo Liang

The Chinese University of Hong Kong

H指数:19

被引数:1,974

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis

更正：受体酪氨酸激酶抑制剂舒尼替尼作为一种新型免疫疗法，用于抑制髓源性抑制性细胞，以治疗子宫内膜异位症。

Frontiers in Immunology

IF5.9

2025-11-240

OAAI

LncRNA and mRNA expression characteristic and bioinformatic analysis in anemic diabetic foot ulcers

LncRNA和mRNA表达特征及生物信息学分析在贫血性糖尿病足溃疡中的应用

Frontiers in Genetics

IF2.8

2025-10-010

OAAI

Correlation analysis of thyroid function and vitamin D levels in patients with type 2 diabetes

2型糖尿病患者甲状腺功能与维生素D水平的相关性分析

Frontiers in Endocrinology

IF4.6

2025-08-140

PRE

A method for determining potential parental contamination: linkage disequilibrium-based log-likelihood ratio analysis for IVF-PGT

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY

IF4.7

2024-10-210

OAAI

Chlorogenic acid supported strontium polyphenol networks ensemble microneedle patch to promote diabetic wound healing

绿原酸支持锶多酚网络集成微针贴片促进糖尿病创面愈合

CHINESE CHEMICAL LETTERS

IF8.9

2024-08-014

PRE

An integrated cofactor and co-substrate recycling pathway for the biosynthesis of 1,5-pentanediol

MICROBIAL CELL FACTORIES

IF4.9

2024-05-061

OA

Glucose Oxidase Energized Osmium with Dual-Active Centers and Triple Enzyme Activities for Infected Diabetic Wound Management

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-04-0210

PRE

Mxene-based mild hyperthemia microneedle patch for diabetic wound healing

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-02-0112

PRE

Comparison of in-patient glucose team based management with conventional blood glucose management- a retrospective study from China

DIABETOLOGY & METABOLIC SYNDROME

IF3.9

2024-01-030

OAAI

Comprehensive analysis of endoplasmic reticulum stress-related mechanisms in type 2 diabetes mellitus

2型糖尿病内质网应激相关机制的综合分析

WORLD JOURNAL OF DIABETES

IF4.6

2023-06-153

OAAI

Fibrinogen function indexes are potential biomarkers for evaluating the occurrence and severity of diabetic foot

DIABETOLOGY & METABOLIC SYNDROME

IF3.9

2022-12-021

OAAI

Re-evaluation of mouse models of endometriosis for pathological and immunological research

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-187

OAAI

Osteoporosis pathogenesis and treatment: existing and emerging avenues

CELLULAR & MOLECULAR BIOLOGY LETTERS

IF10.2

2022-09-0488

OAAI

Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds

BIOACTIVE MATERIALS

IF20.3

2021-09-0160

OAAI

Glycolipid toxicity induces osteogenic dysfunction via the TLR4/S100B pathway

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-08-019

PREAI

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-07-228

OAAI

Novel Genetic Variants of PPARγ2 Promoter in Gestational Diabetes Mellitus and its Molecular Regulation in Adipogenesis

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2021-01-227

OAAI

High T3 Induces β-Cell Insulin Resistance via Endoplasmic Reticulum Stress

MEDIATORS OF INFLAMMATION

IF4.2

2020-07-227

OAAI

Treatment of Polysilicon Production Wastewater by Ferrate(VI) Microcapsule Oxidation and Biological Aerated Biofilter

WATER AIR AND SOIL POLLUTION

IF3

2019-11-026

PREAI

Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines

REPRODUCTIVE TOXICOLOGY

IF2.8

2019-10-0110

PREAI